In part II of her blog series, Cynthia Matossian, MD, FACS, shares why failure to address problems with the tear film and ocular surface before surgery can negatively affect surgical outcomes and patient satisfaction.
ICYMI: Rishi P. Singh, MD, discusses the results of a post hoc analysis between VISTA and VIVID, and the overall sustained diabetic retinopathy severity improvements with intravitreal aflibercept in diabetic macular edema.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
